Molecular	O
cloning	O
of	O
SLAP-130	B-protein
,	O
an	O
SLP-76-associated	B-protein
substrate	I-protein
of	O
the	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor-stimulated	I-protein
protein	I-protein
tyrosine	I-protein
kinases	I-protein
.	O

Previous	O
work	O
has	O
demonstrated	O
that	O
SLP-76	B-protein
,	O
a	O
Grb2-associated	B-protein
tyrosine-phosphorylated	I-protein
protein	I-protein
,	O
augments	O
Interleukin-2	B-DNA
promoter	I-DNA
activity	O
when	O
overexpressed	O
in	O
the	O
Jurkat	B-cell_line
T	I-cell_line
cell	I-cell_line
line	I-cell_line
.	O

This	O
activity	O
requires	O
regions	O
of	O
SLP-76	B-protein
that	O
mediate	O
protein-protein	O
interactions	O
with	O
other	O
molecules	O
in	O
T	B-cell_type
cells	I-cell_type
,	O
suggesting	O
that	O
SLP-76	B-protein
-associated	O
proteins	O
also	O
function	O
to	O
regulate	O
signal	O
transduction	O
.	O

Here	O
we	O
describe	O
the	O
molecular	O
cloning	O
of	O
SLAP-130	B-protein
,	O
a	O
SLP-76-associated	B-protein
phosphoprotein	I-protein
of	O
130	O
kDa	O
.	O

We	O
demonstrate	O
that	O
SLAP-130	B-protein
is	O
hematopoietic	O
cell-specific	O
and	O
associates	O
with	O
the	O
SH2	B-protein
domain	I-protein
of	O
SLP-76	B-protein
.	O

Additionally	O
,	O
we	O
show	O
that	O
SLAP-130	B-protein
is	O
a	O
substrate	O
of	O
the	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor-induced	I-protein
protein	I-protein
tyrosine	B-protein
kinases	I-protein
.	O

Interestingly	O
,	O
we	O
find	O
that	O
in	O
contrast	O
to	O
SLP-76	B-protein
,	O
overexpression	O
of	O
SLAP-130	B-protein
diminishes	O
T	B-protein
cell	I-protein
antigen	I-protein
receptor	I-protein
-induced	O
activation	O
of	O
the	O
interleukin-2	B-DNA
promoter	I-DNA
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
and	O
interferes	O
with	O
the	O
augmentation	O
of	O
interleukin-2	B-DNA
promoter	I-DNA
activity	O
seen	O
when	O
SLP-76	B-protein
is	O
overexpressed	O
in	O
these	O
cells	O
.	O

These	O
data	O
suggest	O
that	O
SLP-76	B-protein
recruits	O
a	O
negative	O
regulator	O
,	O
SLAP-130	B-protein
,	O
as	O
well	O
as	O
positive	O
regulators	O
of	O
signal	O
transduction	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Communication	NULL
Molecular	NULL
Cloning	NULL
of	NULL
SLAP-130	NULL
,	NULL
an	NULL
SLP-76-associated	NULL
Substrate	NULL
of	NULL
the	NULL
T	NULL
Cell	NULL
Antigen	NULL
Receptor-stimulated	NULL
Protein	NULL
Tyrosine	NULL
Kinases*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
23	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
February	NULL
25	NULL
,	NULL
1997	NULL
)	NULL
Michael	NULL
A.	NULL
Musci	NULL
#	NULL
§	NULL
,	NULL
L.	NULL
Ranee	NULL
Hendricks-Taylor	NULL
#	NULL
]	NULL
,	NULL
David	NULL
G.	NULL
Motto|	NULL
,	NULL
Michael	NULL
Paskind**	NULL
,	NULL
Joanne	NULL
Kamens**	NULL
,	NULL
Christoph	NULL
W.	NULL
Turck	NULL
#	NULL
}	NULL
,	NULL
and	NULL
Gary	NULL
A.	NULL
Koretzky§1|	NULL
$	NULL
§	NULL
From	NULL
the	NULL
§Graduate	NULL
Program	NULL
in	NULL
Immunology	NULL
,	NULL
(	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Physiology	NULL
and	NULL
Biophysics	NULL
,	NULL
University	NULL
of	NULL
Iowa	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Iowa	NULL
City	NULL
,	NULL
Iowa	NULL
52242	NULL
,	NULL
the	NULL
**BASF	NULL
Bioresearch	NULL
Corporation	NULL
,	NULL
Worcester	NULL
,	NULL
Massachusetts	NULL
01605	NULL
,	NULL
and	NULL
the	NULL
{	NULL
{	NULL
iHoward	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94143	NULL
Previous	NULL
work	NULL
has	NULL
demonstrated	NULL
that	NULL
SLP-76	NULL
,	NULL
a	NULL
Grb2-associated	NULL
tyrosine-phosphorylated	NULL
protein	NULL
,	NULL
augments	NULL
Interleukin-2	NULL
promoter	NULL
activity	NULL
when	NULL
overexpressed	NULL
in	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
.	NULL

This	NULL
activity	NULL
requires	NULL
regions	NULL
of	NULL
SLP-76	NULL
that	NULL
mediate	NULL
protein-protein	NULL
interactions	NULL
with	NULL
other	NULL
molecules	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
SLP-76-associated	NULL
proteins	NULL
also	NULL
function	NULL
to	NULL
regulate	NULL
signal	NULL
trans-duction	NULL
.	NULL

Here	NULL
we	NULL
describe	NULL
the	NULL
molecular	NULL
cloning	NULL
of	NULL
SLAP-130	NULL
,	NULL
a	NULL
SLP-76-associated	NULL
phosphoprotein	NULL
of	NULL
130	NULL
kDa	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
SLAP-130	NULL
is	NULL
hematopoietic	NULL
cell-specific	NULL
and	NULL
associates	NULL
with	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
show	NULL
that	NULL
SLAP-130	NULL
is	NULL
a	NULL
substrate	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor-induced	NULL
protein	NULL
tyrosine	NULL
ki-nases	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
find	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
SLP-76	NULL
,	NULL
overexpression	NULL
of	NULL
SLAP-130	NULL
diminishes	NULL
T	NULL
cell	NULL
antigen	NULL
receptor-induced	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
interferes	NULL
with	NULL
the	NULL
augmentation	NULL
of	NULL
interleukin-2	NULL
promoter	NULL
activity	NULL
seen	NULL
when	NULL
SLP-76	NULL
is	NULL
overexpressed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
SLP-76	NULL
recruits	NULL
a	NULL
negative	NULL
regulator	NULL
,	NULL
SLAP-130	NULL
,	NULL
as	NULL
well	NULL
as	NULL
positive	NULL
regulators	NULL
of	NULL
signal	NULL
transduction	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
GM53256	NULL
(	NULL
to	NULL
G.	NULL
K.	NULL
)	NULL
,	NULL
the	NULL
University	NULL
of	NULL
Iowa	NULL
Diabetes	NULL
and	NULL
Endo-crinology	NULL
Research	NULL
Center	NULL
Grant	NULL
DK25295	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Interdisciplinary	NULL
Program	NULL
in	NULL
Aging	NULL
Training	NULL
Grant	NULL
AG00214-05	NULL
(	NULL
to	NULL
M.	NULL
M.	NULL
)	NULL
,	NULL
and	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Training	NULL
Grant	NULL
HLO7638	NULL
(	NULL
to	NULL
D.	NULL
M.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
These	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

§§	NULL
Established	NULL
investigator	NULL
of	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
and	NULL
is	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
Roy	NULL
J	NULL
.	NULL

Carver	NULL
Charitable	NULL
Trust	NULL
.	NULL

To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
University	NULL
of	NULL
Iowa	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Dept	NULL
.	NULL

of	NULL
Internal	NULL
Medicine	NULL
,	NULL
540	NULL
EMRB	NULL
,	NULL
Iowa	NULL
City	NULL
,	NULL
IA	NULL
52242	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
819-835-6844	NULL
;	NULL
Fax	NULL
:	NULL
819-885-6887	NULL
;	NULL
E-mail	NULL
:	NULL
gary-koretzky	NULL
@	NULL
uiowa.edu	NULL
.	NULL

11674	NULL
THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

18	NULL
,	NULL
Issue	NULL
of	NULL
May	NULL
2	NULL
,	NULL
pp	NULL
.	NULL

11674-11677	NULL
,	NULL
1997	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc	NULL
.	NULL

Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Engagement	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTK	NULL
)	NULL
and	NULL
the	NULL
subsequent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
numerous	NULL
proteins	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Our	NULL
efforts	NULL
to	NULL
characterize	NULL
substrates	NULL
of	NULL
the	NULL
TCR-induced	NULL
PTK	NULL
activity	NULL
led	NULL
to	NULL
the	NULL
cloning	NULL
of	NULL
SLP-76	NULL
,	NULL
a	NULL
tyrosine-phosphorylated	NULL
hematopoietic	NULL
cell-specific	NULL
protein	NULL
that	NULL
associates	NULL
with	NULL
the	NULL
SH3	NULL
domains	NULL
of	NULL
Grb2	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

A	NULL
possible	NULL
function	NULL
of	NULL
SLP-76	NULL
in	NULL
T	NULL
cells	NULL
was	NULL
suggested	NULL
by	NULL
experiments	NULL
showing	NULL
that	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
augments	NULL
TCR-mediated	NULL
signals	NULL
that	NULL
lead	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
promoter	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
SLP-76	NULL
requires	NULL
engagement	NULL
of	NULL
the	NULL
TCR	NULL
and	NULL
that	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
results	NULL
in	NULL
increased	NULL
activation	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
cascade	NULL
following	NULL
TCR	NULL
ligation	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
three	NULL
distinct	NULL
regions	NULL
of	NULL
SLP-76	NULL
that	NULL
are	NULL
responsible	NULL
for	NULL
protein-protein	NULL
interactions	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
required	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
augment	NULL
IL-2	NULL
promoter	NULL
activity	NULL
when	NULL
overexpressed	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL
``	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
SLP-76	NULL
functions	NULL
as	NULL
a	NULL
link	NULL
between	NULL
proteins	NULL
that	NULL
regulate	NULL
signals	NULL
generated	NULL
by	NULL
TCR	NULL
ligation	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
function	NULL
of	NULL
SLP-76	NULL
in	NULL
T	NULL
cells	NULL
further	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
begun	NULL
to	NULL
characterize	NULL
SLP-76-associated	NULL
proteins	NULL
that	NULL
may	NULL
participate	NULL
with	NULL
SLP-76	NULL
in	NULL
transducing	NULL
signals	NULL
from	NULL
the	NULL
TCR	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

These	NULL
proteins	NULL
include	NULL
Vav	NULL
,	NULL
which	NULL
associates	NULL
with	NULL
the	NULL
amino-terminal	NULL
acidic	NULL
region	NULL
of	NULL
SLP-76	NULL
in	NULL
a	NULL
phosphotyrosine-dependent	NULL
manner	NULL
(	NULL
5	NULL
,	NULL
8	NULL
,	NULL
9	NULL
)	NULL
;	NULL
the	NULL
adapter	NULL
protein	NULL
Grb2	NULL
,	NULL
which	NULL
interacts	NULL
with	NULL
a	NULL
proline-rich	NULL
motif	NULL
of	NULL
SLP-76	NULL
via	NULL
its	NULL
SH3	NULL
domains	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
;	NULL
and	NULL
two	NULL
unidentified	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
of	NULL
64	NULL
and	NULL
130	NULL
kDa	NULL
and	NULL
a	NULL
serine/threonine	NULL
kinase	NULL
,	NULL
all	NULL
of	NULL
which	NULL
associate	NULL
with	NULL
the	NULL
carboxyl-terminal	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
report	NULL
the	NULL
cloning	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
a	NULL
130-kDa	NULL
protein	NULL
(	NULL
SLAP-130	NULL
for	NULL
SLP-76	NULL
associated	NULL
phosphoprotein	NULL
of	NULL
130	NULL
kDa	NULL
)	NULL
that	NULL
associates	NULL
with	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
SLAP-130	NULL
may	NULL
function	NULL
as	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
TCR	NULL
signals	NULL
that	NULL
activate	NULL
IL-2	NULL
gene	NULL
transcription	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
Cell	NULL
Culture-Jurkat	NULL
T	NULL
cells	NULL
were	NULL
maintained	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

JAZ/SLP-SH2	NULL
,	NULL
a	NULL
Jurkat	NULL
T	NULL
cell	NULL
variant	NULL
expressing	NULL
an	NULL
A2/SLP-SH2	NULL
chimera	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
mg/ml	NULL
ge-neticin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

cDNA	NULL
Constructs-The	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
and	NULL
subcloned	NULL
in	NULL
frame	NULL
with	NULL
HLA-A2	NULL
in	NULL
peDNABS/A2/HCP	NULL
(	NULL
10	NULL
)	NULL
to	NULL
generate	NULL
peDNAS/A2/SLP-SH2	NULL
.	NULL

The	NULL
amino-terminal	NULL
1850	NULL
nucleotides	NULL
of	NULL
SLAP-180	NULL
were	NULL
amplified	NULL
from	NULL
Jurkat	NULL
RNA	NULL
and	NULL
ligated	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
FLAG	NULL
tag	NULL
in	NULL
pEF/SLP-76	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
3	NULL
'	NULL
cDNA	NULL
was	NULL
amplified	NULL
from	NULL
Jurkat	NULL
RNA	NULL
by	NULL
overlap	NULL
extension	NULL
PCR	NULL
.	NULL

The	NULL
resulting	NULL
fragment	NULL
was	NULL
ligated	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
amino-terminal	NULL
1850	NULL
bp	NULL
in	NULL
pEF	NULL
above	NULL
to	NULL
create	NULL
pEF/SLAP-130	NULL
.	NULL

pEF/A2	NULL
,	NULL
the	NULL
expression	NULL
vector	NULL
containing	NULL
HLA-A2	NULL
cDNA	NULL
,	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
B.	NULL
Shraven	NULL
(	NULL
University	NULL
of	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

NFAT-luec	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
G.	NULL
Crabtree	NULL
(	NULL
Stanford	NULL
University	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
expressed	NULL
sequence-tagged	NULL
(	NULL
EST	NULL
)	NULL
clone	NULL
(	NULL
I.M.A.G.E	NULL
.	NULL

consortium	NULL
ID	NULL
number	NULL
241254	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Genome	NULL
Systems	NULL
,	NULL
Inc.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Antibodies-Anti-A2	NULL
mAb	NULL
CR11-851	NULL
(	NULL
gift	NULL
of	NULL
C.	NULL
Lutz	NULL
,	NULL
University	NULL
of	NULL
Towa	NULL
,	NULL
Iowa	NULL
City	NULL
,	NULL
IA	NULL
)	NULL
.	NULL

Anti-TCR	NULL
mAb	NULL
C305	NULL
(	NULL
gift	NULL
of	NULL
A.	NULL
Weiss	NULL
,	NULL
University	NULL
*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
;	NULL
PTK	NULL
,	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
;	NULL
NFAT	NULL
,	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
GST	NULL
,	NULL
glutathi-one	NULL
S-transferase	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
EST	NULL
,	NULL
expressed	NULL
sequence-tagged	NULL
;	NULL
RACE	NULL
,	NULL
rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
ends	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

2	NULL
M.	NULL
A.	NULL
Musci	NULL
,	NULL
D.	NULL
G.	NULL
Motto	NULL
,	NULL
S.	NULL
E.	NULL
Ross	NULL
,	NULL
N.	NULL
Fang	NULL
,	NULL
and	NULL
G.	NULL
A.	NULL
Koretzky	NULL
,	NULL
submitted	NULL
for	NULL
publication	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www-jbc.stanford.edu/jbc/	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
SLAP-130	NULL
,	NULL
a	NULL
Novel	NULL
Substrate	NULL
of	NULL
the	NULL
TCR-stimulated	NULL
PTK	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Anti-FLAG	NULL
mAb	NULL
M2	NULL
(	NULL
International	NULL
Biotechnologies	NULL
Inc.	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

Anti-phosphotyrosine	NULL
mAb	NULL
4G10	NULL
(	NULL
Upstate	NULL
Biotechnologies	NULL
Inc.	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Horseradish	NULL
peroxi-dase-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
and	NULL
goat	NULL
anti-sheep	NULL
antiserum	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Anti-SLP-76	NULL
sheep	NULL
antiserum	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Anti-SLAP-180	NULL
sheep	NULL
antiserum	NULL
was	NULL
generated	NULL
against	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
containing	NULL
amino	NULL
acids	NULL
1-840	NULL
of	NULL
human	NULL
SLAP-130	NULL
.	NULL

Immunoprecipitations-Cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
(	NULL
C305	NULL
acites	NULL
,	NULL
1:1000	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
or	NULL
pervanadate	NULL
(	NULL
11	NULL
)	NULL
for	NULL
1	NULL
min	NULL
and	NULL
lysed	NULL
in	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
)	NULL
.	NULL

For	NULL
immunoprecipitations	NULL
,	NULL
antibodies	NULL
were	NULL
conjugated	NULL
to	NULL
GammaBind	NULL
Plus	NULL
Sepharose	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Lysates	NULL
were	NULL
subjected	NULL
to	NULL
precipitation	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
or	NULL
GST	NULL
fusion	NULL
protein	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Precipitated	NULL
complexes	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
in	NULL
high	NULL
salt	NULL
lysis	NULL
buffer	NULL
(	NULL
500	NULL
mM	NULL
NaCl	NULL
)	NULL
,	NULL
resolved	NULL
by	NULL
reducing	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Cloning	NULL
of	NULL
Human	NULL
pp130	NULL
cDNA-A	NULL
large	NULL
scale	NULL
anti-A2	NULL
immunoprecipitation	NULL
of	NULL
pervanadate-stimulated	NULL
JA2Z/SLP-SH2	NULL
cells	NULL
was	NULL
subjected	NULL
to	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
(	NULL
Mil-lipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
Ponceau	NULL
S	NULL
staining	NULL
.	NULL

The	NULL
protein	NULL
band	NULL
of	NULL
130	NULL
kDa	NULL
was	NULL
excised	NULL
and	NULL
subjected	NULL
to	NULL
trypsin	NULL
digestion	NULL
and	NULL
reverse	NULL
phase	NULL
high	NULL
performance	NULL
liquid	NULL
chromatography	NULL
for	NULL
protein	NULL
sequencing	NULL
.	NULL

Individual	NULL
peptides	NULL
were	NULL
sequenced	NULL
using	NULL
a	NULL
Procise	NULL
492	NULL
protein	NULL
sequencer	NULL
(	NULL
Perkin-Elmer/ABD	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

One	NULL
peptide	NULL
sequence	NULL
,	NULL
PPNVDLTK	NULL
,	NULL
was	NULL
represented	NULL
in	NULL
an	NULL
EST	NULL
clone	NULL
containing	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
1074	NULL
bp	NULL
.	NULL

Nucleotides	NULL
1088-1266	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
from	NULL
the	NULL
EST	NULL
and	NULL
used	NULL
to	NULL
screen	NULL
a	NULL
human	NULL
thymus	NULL
Agt10	NULL
cDNA	NULL
library	NULL
(	NULL
#	NULL
NL1127a	NULL
,	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

A	NULL
A	NULL
clone	NULL
was	NULL
identified	NULL
containing	NULL
1008	NULL
bp	NULL
5¢	NULL
of	NULL
the	NULL
EST	NULL
.	NULL

The	NULL
remaining	NULL
cDNA	NULL
was	NULL
amplified	NULL
from	NULL
Jurkat	NULL
cDNA	NULL
by	NULL
3	NULL
``	NULL
RACE	NULL
(	NULL
rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
ends	NULL
)	NULL
using	NULL
the	NULL
Marathon	NULL
cDNA	NULL
Amplification	NULL
Kit	NULL
(	NULL
CLONTECH	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Independent	NULL
amplification	NULL
of	NULL
the	NULL
entire	NULL
coding	NULL
sequence	NULL
of	NULL
SLAP-180	NULL
from	NULL
Jurkat	NULL
RNA	NULL
was	NULL
performed	NULL
by	NULL
RT-PCR	NULL
using	NULL
the	NULL
GeneAmp	NULL
kit	NULL
(	NULL
Perkin-Elmer	NULL
)	NULL
.	NULL

Northern	NULL
Analysis-Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
following	NULL
the	NULL
protocols	NULL
included	NULL
with	NULL
the	NULL
human	NULL
multiple	NULL
tissue	NULL
Northern	NULL
Blots	NULL
I	NULL
and	NULL
II	NULL
(	NULL
CLONTECH	NULL
)	NULL
.	NULL

A	NULL
SLAP-130	NULL
PCR	NULL
product	NULL
(	NULL
nucleotides	NULL
1088-1266	NULL
)	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
a-*°PIdCTP	NULL
(	NULL
Amersham	NULL
)	NULL
by	NULL
random	NULL
priming	NULL
and	NULL
hybridized	NULL
to	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
multiple	NULL
tissues	NULL
.	NULL

Transfections	NULL
and	NULL
NFAT	NULL
Luciferase	NULL
Assays-Cells	NULL
were	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
suspended	NULL
in	NULL
cytomix	NULL
(	NULL
12	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells/400	NULL
ul	NULL
of	NULL
cytomix/cuvette	NULL
.	NULL

Cells	NULL
were	NULL
electropo-rated	NULL
at	NULL
250V	NULL
,	NULL
960uF	NULL
using	NULL
a	NULL
Gene	NULL
Pulser	NULL
(	NULL
Bio-Rad	NULL
)	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
NFAT-luc	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
cytomegalovirus-B-galactosidase	NULL
,	NULL
and	NULL
40	NULL
ug	NULL
of	NULL
either	NULL
pEF/SLP-76	NULL
or	NULL
pEF/SLAP-130	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
plasmid	NULL
DNA	NULL
was	NULL
equilibrated	NULL
to	NULL
100	NULL
ug	NULL
with	NULL
the	NULL
vector	NULL
control	NULL
pEF/A2	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
stimulated	NULL
in	NULL
triplicate	NULL
for	NULL
10	NULL
h	NULL
with	NULL
media	NULL
or	NULL
anti-TCR	NULL
mAb	NULL
C805	NULL
(	NULL
ascites	NULL
1:1000	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
triplicate	NULL
samples	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
unstimulated	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
using	NULL
the	NULL
Galacto-Light	NULL
Plus	NULL
Reporter	NULL
Gene	NULL
Assay	NULL
System	NULL
(	NULL
Tropix	NULL
Inc.	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Luciferase	NULL
light	NULL
units	NULL
were	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
present	NULL
in	NULL
each	NULL
transfectant	NULL
to	NULL
standardize	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Cloning	NULL
of	NULL
cDNA	NULL
Encoding	NULL
SLAP-130-We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
associates	NULL
with	NULL
two	NULL
unidentified	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
upon	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
either	NULL
anti-TCR	NULL
mAb	NULL
or	NULL
the	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
inhibitor	NULL
pervanadate	NULL
(	NULL
4	NULL
)	NULL
.	NULL

To	NULL
facilitate	NULL
purification	NULL
of	NULL
these	NULL
SLP-76-associated	NULL
proteins	NULL
,	NULL
we	NULL
established	NULL
a	NULL
variant	NULL
of	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
JA¥/SLP-SH2	NULL
,	NULL
which	NULL
expresses	NULL
a	NULL
chimeric	NULL
surface	NULL
protein	NULL
consisting	NULL
of	NULL
the	NULL
extracel-lular	NULL
and	NULL
transmembrane	NULL
domains	NULL
of	NULL
the	NULL
HLA-A2	NULL
molecule	NULL
in	NULL
frame	NULL
with	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
.	NULL

The	NULL
A2	NULL
epitope	NULL
enabled	NULL
the	NULL
isolation	NULL
of	NULL
proteins	NULL
associated	NULL
with	NULL
the	NULL
SLP-76	NULL
SH2	NULL
domain	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
anti-A2	NULL
mAb	NULL
.	NULL

JA2/SLP-SH2	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
pervanadate	NULL
for	NULL
maximal	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
proteins	NULL
and	NULL
lysed	NULL
in	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
.	NULL

Anti-A2	NULL
immunoprecipitates	NULL
were	NULL
resolved	NULL
on	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
.	NULL

A	NULL
single	NULL
major	NULL
species	NULL
of	NULL
approximately	NULL
130	NULL
kDa	NULL
was	NULL
excised	NULL
and	NULL
subjected	NULL
to	NULL
tryptic	NULL
digestion	NULL
to	NULL
generate	NULL
peptides	NULL
for	NULL
protein	NULL
sequencing	NULL
.	NULL

One	NULL
peptide	NULL
se	NULL
11675	NULL
quence	NULL
,	NULL
PPNDVLTK	NULL
,	NULL
was	NULL
represented	NULL
in	NULL
an	NULL
EST	NULL
clone	NULL
.	NULL

Se	NULL
quencing	NULL
this	NULL
clone	NULL
revealed	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
over	NULL
1000	NULL
bp	NULL
.	NULL

A	NULL
region	NULL
of	NULL
this	NULL
clone	NULL
was	NULL
then	NULL
used	NULL
to	NULL
probe	NULL
a	NULL
human	NULL
thymus	NULL
Agt10	NULL
cDNA	NULL
library	NULL
to	NULL
obtain	NULL
further	NULL
sequence	NULL
.	NULL

A	NULL
cDNA	NULL
clone	NULL
containing	NULL
370	NULL
bp	NULL
of	NULL
the	NULL
EST	NULL
sequence	NULL
and	NULL
an	NULL
additional	NULL
1008	NULL
bp	NULL
of	NULL
coding	NULL
sequence	NULL
5	NULL
'	NULL
of	NULL
the	NULL
EST	NULL
was	NULL
isolated	NULL
and	NULL
found	NULL
to	NULL
contain	NULL
a	NULL
putative	NULL
start	NULL
site	NULL
27	NULL
bases	NULL
downstream	NULL
of	NULL
a	NULL
stop	NULL
codon	NULL
.	NULL

A	NULL
cDNA	NULL
containing	NULL
the	NULL
remaining	NULL
3'-coding	NULL
sequence	NULL
was	NULL
amplified	NULL
from	NULL
Jurkat	NULL
cDNA	NULL
by	NULL
3	NULL
!	NULL

RACE	NULL
and	NULL
contained	NULL
267	NULL
additional	NULL
bases	NULL
of	NULL
coding	NULL
sequence	NULL
followed	NULL
by	NULL
a	NULL
stop	NULL
codon	NULL
2349	NULL
bases	NULL
downstream	NULL
of	NULL
the	NULL
putative	NULL
start	NULL
.	NULL

A	NULL
contiguous	NULL
cDNA	NULL
was	NULL
generated	NULL
by	NULL
RT-PCR	NULL
amplification	NULL
of	NULL
pp130	NULL
from	NULL
Jurkat	NULL
RNA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
sequence	NULL
was	NULL
confirmed	NULL
by	NULL
sequencing	NULL
the	NULL
product	NULL
of	NULL
multiple	NULL
independent	NULL
RT-PCR	NULL
reactions	NULL
.	NULL

We	NULL
have	NULL
designated	NULL
this	NULL
protein	NULL
SLAP-130	NULL
for	NULL
SLP-76	NULL
associated	NULL
phosphoprotein	NULL
of	NULL
130	NULL
kDa	NULL
.	NULL

The	NULL
complete	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
SLAP-130	NULL
consists	NULL
of	NULL
2349	NULL
bp	NULL
translating	NULL
to	NULL
a	NULL
protein	NULL
of	NULL
783	NULL
amino	NULL
acids	NULL
with	NULL
an	NULL
abundance	NULL
of	NULL
proline	NULL
(	NULL
12	NULL
%	NULL
)	NULL
and	NULL
charged	NULL
(	NULL
81	NULL
%	NULL
)	NULL
residues	NULL
.	NULL

Putative	NULL
nuclear	NULL
localization	NULL
sequences	NULL
are	NULL
found	NULL
within	NULL
amino	NULL
acids	NULL
480-503	NULL
and	NULL
683-700	NULL
(	NULL
Ref	NULL
.	NULL

13	NULL
and	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
yet	NULL
whether	NULL
SLAP-130	NULL
is	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

There	NULL
are	NULL
several	NULL
potential	NULL
tyrosine	NULL
phosphorylation	NULL
sites	NULL
in	NULL
the	NULL
carboxyl-terminal	NULL
region	NULL
of	NULL
the	NULL
molecule	NULL
that	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
SLAP-130	NULL
with	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
there	NULL
are	NULL
four	NULL
tyrosines	NULL
(	NULL
resi-dues	NULL
462	NULL
,	NULL
595	NULL
,	NULL
651	NULL
,	NULL
and	NULL
771	NULL
)	NULL
present	NULL
in	NULL
motifs	NULL
that	NULL
may	NULL
mediate	NULL
binding	NULL
to	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
sre	NULL
family	NULL
kinases	NULL
(	NULL
14	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
SLAP-130	NULL
may	NULL
interact	NULL
with	NULL
proteins	NULL
other	NULL
than	NULL
SLP-76	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Tissue	NULL
Distribution	NULL
of	NULL
SLAP-130-Northern	NULL
blot	NULL
analysis	NULL
of	NULL
human	NULL
mRNA	NULL
from	NULL
multiple	NULL
tissues	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
the	NULL
tissue	NULL
distribution	NULL
of	NULL
SLAP-130	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
SLAP-130	NULL
mRNA	NULL
is	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
tissues	NULL
(	NULL
pe-ripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
thymus	NULL
)	NULL
but	NULL
not	NULL
in	NULL
non-lymphoid	NULL
tissues	NULL
.	NULL

Additionally	NULL
,	NULL
SLAP-130	NULL
was	NULL
amplified	NULL
as	NULL
a	NULL
single	NULL
product	NULL
from	NULL
total	NULL
Jurkat	NULL
RNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
demonstrating	NULL
expression	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
.	NULL

Expression	NULL
of	NULL
cDNA	NULL
Encoding	NULL
SLAP-130	NULL
Results	NULL
in	NULL
a	NULL
Protein	NULL
That	NULL
Migrates	NULL
Similarly	NULL
to	NULL
pp130-Translation	NULL
of	NULL
the	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
the	NULL
SLAP-130	NULL
cDNA	NULL
predicts	NULL
a	NULL
protein	NULL
with	NULL
a	NULL
molecular	NULL
mass	NULL
of	NULL
86	NULL
kDa	NULL
.	NULL

However	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
stop	NULL
codons	NULL
flanking	NULL
both	NULL
the	NULL
5	NULL
and	NULL
3	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
putative	NULL
coding	NULL
sequence	NULL
suggested	NULL
that	NULL
we	NULL
had	NULL
isolated	NULL
the	NULL
full-length	NULL
cDNA	NULL
encoding	NULL
a	NULL
130-kDa	NULL
,	NULL
SLP-76-associated	NULL
protein	NULL
.	NULL

This	NULL
was	NULL
confirmed	NULL
by	NULL
generating	NULL
an	NULL
epitope	NULL
(	NULL
FLAG	NULL
)	NULL
-tagged	NULL
version	NULL
of	NULL
SLAP-130	NULL
cDNA	NULL
(	NULL
pEF/SLAP-130	NULL
)	NULL
for	NULL
transient	NULL
expression	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
transfection	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
pEF/SLAP-130	NULL
results	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
protein	NULL
reactive	NULL
with	NULL
anti-FLAG	NULL
mAb	NULL
that	NULL
migrates	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
130	NULL
kDa	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
does	NULL
not	NULL
appear	NULL
in	NULL
lysates	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
control	NULL
vector	NULL
pEF	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
.	NULL

Whether	NULL
the	NULL
apparent	NULL
migration	NULL
of	NULL
SLAP-130	NULL
at	NULL
130	NULL
kDa	NULL
instead	NULL
of	NULL
the	NULL
predicted	NULL
86	NULL
kDa	NULL
results	NULL
from	NULL
post-translational	NULL
modifications	NULL
or	NULL
the	NULL
abundance	NULL
of	NULL
charged	NULL
amino	NULL
acids	NULL
present	NULL
in	NULL
the	NULL
molecule	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
.	NULL

To	NULL
investigate	NULL
further	NULL
whether	NULL
the	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
SLAP-130	NULL
cDNA	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
130-kDa	NULL
,	NULL
SLP-76-associated	NULL
phosphoprotein	NULL
,	NULL
we	NULL
prepared	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
containing	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
(	NULL
GST/SH2	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
this	NULL
fusion	NULL
protein	NULL
precipitates	NULL
epitope-tagged	NULL
SLAP-130	NULL
from	NULL
pervanadate-stimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
but	NULL
not	NULL
from	NULL
resting	NULL
cells	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
transfected	NULL
with	NULL
pEF/SLAP-130	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
function	NULL
mutant	NULL
of	NULL
the	NULL
SLP-76	NULL
SH2	NULL
domain	NULL
when	NULL
expressed	NULL
as	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
(	NULL
GST/R448K	NULL
)	NULL
fails	NULL
to	NULL
associate	NULL
with	NULL
FLAG-SLAP-130	NULL
in	NULL
either	NULL
resting	NULL
or	NULL
pervanadate-stimulated	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
11676	NULL
1	NULL
>	NULL
TAGGATGGAAACCCAGATCTAAAGTCCCTCATGGCGAAATATAACACGGGGGGCAACCCGACAGAGGATGTCTCA	NULL
45	NULL
20	NULL
b	NULL
G	NULL
K	NULL
A	NULL
Db	NULL
V	NULL
X®	NULL
S	NULL
L	NULL
M	NULL
A	NULL
K	NULL
¥	NULL
N	NULL
f	NULL
G	NULL
c	NULL
w	NULL
»	NULL
f	NULL
BE	NULL
b	NULL
v	NULL
§	NULL
15	NULL
emcaaTACCCOACCCPTCAGACICACAGGGCCARACTCATCPPCAGGAATACAACCAAGAAAGAACTPATTCAAC	NULL
-	NULL
120	NULL
v	NULL
N	NULL
s	NULL
RoRok	NULL
ROV	NULL
T	NULL
G	NULL
BON	NULL
s	NULL
s	NULL
s	NULL
G	NULL
I	NULL
Q	NULL
A	NULL
R	NULL
X	NULL
LOF	NULL
N	NULL
40	NULL
AACCAAGGAAATCCCAGCCCTCCTECAGGACCCAGCaATSTACCTAAGTTTGGSTCCCCAAAGCCACCTGTeGCA	NULL
|	NULL
195	NULL
x	NULL
g	NULL
e	NULL
N	NULL
A	NULL
s	NULL
B	NULL
p	NULL
A	NULL
G	NULL
Bos	NULL
N	NULL
V	NULL
B	NULL
k	NULL
F	NULL
@	NULL
s	NULL
2	NULL
K	NULL
B	NULL
P	NULL
Y	NULL
A	NULL
65	NULL
|	NULL
270	NULL
v	NULL
ok	NULL
Bos	NULL
s	NULL
®	NULL
E	NULL
K	NULL
®	NULL
D	NULL
K	NULL
E	NULL
BPoK	NULL
P	NULL
F	NULL
s	NULL
To	NULL
G	NULL
A	NULL
6	NULL
Q	NULL
90	NULL
AcATTCeqacACcAGCcAGCTTeaccACCAGAGACCCCGAGGCGmaAGTGGGATTTCTeAAACCTeTAGGCCCC	NULL
-	NULL
345	NULL
R	NULL
BOG	NULL
T	NULL
B	NULL
A	NULL
8	NULL
LOT	NULL
T	NULL
R	NULL
OD	NULL
POE	NULL
A	NULL
K	NULL
\	NULL
FOL	NULL
k	NULL
P	NULL
V	NULL
G	NULL
P	NULL
voc	NULL
115	NULL
AAGCCCATCAACTTGCCCAAAGAACATTCCAAACCTACATPTCCCTGSCOPCCTGGAAACAAGCCATCTCPTCAC	NULL
-	NULL
420	NULL
KORB	NULL
If	NULL
N	NULL
L	NULL
PORK	NULL
R	NULL
D	NULL
S	NULL
K	NULL
BOT	NULL
FOP	NULL
W	NULL
oP	NULL
NOK	NULL
Pos	NULL
140	NULL
AGTGTAAACCAAGACCATGACTTARACCCACTAGGCCCGAAATCTGGRCCTACTCOTCCAACCTCAGAAAATGAA	NULL
425	NULL
s	NULL
VY	NULL
N	NULL
q	NULL
b	NULL
H	NULL
D	NULL
L	NULL
X	NULL
B	NULL
L	NULL
G	NULL
BoK	NULL
s	NULL
G	NULL
ToR	NULL
oBRom	NULL
3	NULL
®	NULL
N	NULL
B	NULL
155	NULL
CRGAAGCRAGCOTTTCCCAAATTGACTGGCCTTAAACGGAAATTTATGTCAGCATCACAAGATCTTEAACCCAAG	NULL
|	NULL
570	NULL
Q	NULL
K	NULL
Q	NULL
A	NULL
FoR	NULL
kK	NULL
L	NULL
Om	NULL
c	NULL
v	NULL
k	NULL
G	NULL
K	NULL
F	NULL
m	NULL
s	NULL
A	NULL
S	NULL
o	NULL
n	NULL
%	NULL
BoK	NULL
120	NULL
-	NULL
545	NULL
PoL	NULL
RoR	NULL
K	NULL
P	NULL
A	NULL
POG	NULL
9	NULL
s	NULL
T	NULL
E	NULL
N	NULL
s	NULL
HOB	NULL
D	NULL
E	NULL
8	NULL
P	NULL
215	NULL
ATGAAGAATGTGTCTTCATCAAAAGGGTCCCCAGCTCCCCTGGGAGTCAGGTCCAAAAGCGSCCCTTTAAAACCA	NULL
|	NULL
720	NULL
MOK	NULL
N	NULL
v	NULL
S	NULL
s	NULL
s	NULL
k	NULL
G	NULL
s	NULL
BoA	NULL
Bob	NULL
G	NULL
Vy	NULL
R	NULL
s	NULL
K	NULL
s	NULL
6	NULL
P	NULL
OL	NULL
K	NULL
P	NULL
240	NULL
GCAAGGGAAGACTCAG	NULL
TAAMGACCATGC	NULL
TPPCAACTTIOCCCTITCCPEGACTCGPTPTGAA®A	NULL
|	NULL
7	NULL
9	NULL
?	NULL

A	NULL
ROE	NULL
D	NULL
S	NULL
E	NULL
M	NULL
XK	NULL
D	NULL
E	NULL
A	NULL
G	NULL
I	NULL
S	NULL
s	NULL
Lb	NULL
ror	NULL
v	NULL
L	NULL
K	NULL
265	NULL
comeomeccaGccAGGeGACcCcTAGGTCTCICaAAAATCGTGAAGAAAAAAAGGAACATAGSAAGATAGATGCT	NULL
-	NULL
879	NULL
POA	NULL
A	NULL
S	NULL
R	NULL
G	NULL
6	NULL
L	NULL
G	NULL
L	NULL
8	NULL
K	NULL
N	NULL
G	NULL
E	NULL
E	NULL
X	NULL
K	NULL
E	NULL
D	NULL
R	NULL
K	NULL
I	NULL
D	NULL
A	NULL
290	NULL
GCTAAGAACACCTTCCAGAGCAARATAAATCAGGAAGAGTTGGCCTCAGGGACTCCTCCTeccaserTcccraac	NULL
945	NULL
A	NULL
K	NULL
N	NULL
T	NULL
F	NULL
Q	NULL
8	NULL
K	NULL
I	NULL
N	NULL
Q	NULL
B	NULL
OE	NULL
L	NULL
A	NULL
S	NULL
G	NULL
T	NULL
B	NULL
P	NULL
A	NULL
ROF	NULL
BoK	NULL
315	NULL
ceccamececccaaaGTcaccaaAAGGAAAAGGCAGACAASAATTCASCC	NULL
1020	NULL
A	NULL
P	NULL
Lom	NULL
v	NULL
G	NULL
G	NULL
Pow	NULL
c	NULL
g	NULL
s	NULL
q	NULL
E	NULL
K	NULL
B	NULL
K	NULL
@	NULL
D	NULL
K	NULL
N	NULL
S	NULL
A	NULL
340	NULL
ACCCCGAAACAGAAGCCATTGCCTCCCTTGTTIRCCTTGGGTCCACCTCCACCAAAACCCAACAGACCACCAAAT	NULL
1025	NULL
top	NULL
X	NULL
Q	NULL
E	NULL
BOL	NULL
B	NULL
BOL	NULL
ROT	NULL
L	NULL
G	NULL
B	NULL
BOB	NULL
R	NULL
X	NULL
BON	NULL
R	NULL
BO	NULL
365	NULL
emmeaccTercGaaATTCCACAAAACCTCTTCTGGAAACACTACTAGCAAAGGCCAGACCTCTTACTCAACAACP	NULL
1170	NULL
m	NULL
DkO®F	NULL
H	NULL
®	NULL
T	NULL
s	NULL
s	NULL
G	NULL
N	NULL
s	NULL
t	NULL
s	NULL
k	NULL
G	NULL
som	NULL
t	NULL
330	NULL
TCCCTeCcaCCACCTCCACCATCCCATCCGSCCAGCCAZCCRCCATTECCAGCATCTCACCCATCACAACCACCA	NULL
1245	NULL
s	NULL
L	NULL
P	NULL
P	NULL
B	NULL
P	NULL
BOS	NULL
HoB	NULL
A	NULL
S	NULL
q	NULL
b	NULL
B	NULL
L	NULL
BoA	NULL
S	NULL
H	NULL
P	NULL
S	NULL
q	NULL
B	NULL
P	NULL
415	NULL
GTCCCAAGCCTACCTCCCAGAAACATTAAACCTCCGTTTCACCTAAAAAGCCCTGTCAATCAACACARTCAAGAT	NULL
1320	NULL
v	NULL
B	NULL
s	NULL
L	NULL
B	NULL
BOR	NULL
N	NULL
I	NULL
X	NULL
BoR	NULL
OF	NULL
b	NULL
L	NULL
k	NULL
$	NULL
BOV	NULL
N	NULL
E	NULL
D	NULL
N	NULL
Q	NULL
D	NULL
440	NULL
corencacacactCreaTeerccTecaaATCTAGATGAGCAACAACACACTCAAGCACAAACATATGAACACATA	NULL
1395	NULL
ov	NULL
r	NULL
x	NULL
s	NULL
A	NULL
G	NULL
N	NULL
L	NULL
D	NULL
B	NULL
B	NULL
Q	NULL
D	NULL
S	NULL
E	NULL
G	NULL
R	NULL
T	NULL
v	NULL
E	NULL
b	NULL
I	NULL
465	NULL
GAA	NULL
CRAG	NULL
TTaGAGcrce	NULL
GGAACAG	NULL
1470	NULL
EOR	NULL
E	NULL
X	NULL
K	NULL
ROR	NULL
K	NULL
B	NULL
B	NULL
K	NULL
k	NULL
R	NULL
L	NULL
BE	NULL
L	NULL
E	NULL
K	NULL
K	NULL
E	NULL
Q-	NULL
490	NULL
AAAGAGAAAGAAAAGAAAGAACAAGAAATAAAGAAGAAATITAACTAACAGGCCCTATTCAAGTCATCCATCTT	NULL
1545	NULL
KOR	NULL
X	NULL
®	NULL
X	NULL
K	NULL
B	NULL
Q	NULL
®	NULL
I	NULL
K	NULL
K	NULL
K	NULL
F	NULL
K	NULL
L	NULL
T	NULL
G	NULL
B	NULL
oI	NULL
Q	NULL
v	NULL
If	NULL
H	NULL
L	NULL
S515	NULL
GCARAAGCTTGTTGTGATGTCAAAGGAGGAAAGARTGAACTGAGCTTCAACCAACGAGAGCAAATTGAAATCATC	NULL
1620	NULL
A	NULL
K	NULL
A	NULL
C	NULL
C	NULL
p	NULL
y	NULL
k	NULL
G	NULL
@	NULL
k	NULL
N	NULL
E	NULL
L	NULL
s	NULL
F	NULL
K	NULL
g	NULL
oc	NULL
®	NULL
q	NULL
I	NULL
E	NULL
I	NULL
Io	NULL
540	NULL
GAAGCATCC	NULL
G	NULL
E	NULL
A	NULL
S	NULL
K	NULL
CocATCACACACAACCCACGAAGCAAAATCCTTOCGCZCAACAGCAAGGCGTTCATATCGCTATATTARAACAACT	NULL
1695	NULL
PoE	NULL
G	NULL
Kow	NULL
L	NULL
G	NULL
®	NULL
T	NULL
A	NULL
R	NULL
G	NULL
s	NULL
¥	NULL
G	NULL
¥	NULL
I	NULL
K	NULL
RoI	NULL
®	NULL
T	NULL
565	NULL
GCTOTAGAGATTGACTATGATTCTTTGAAACTGAAAAAAGACTCTCTTGGTGCCCCTTCAAGACCTATTGAAGAT	NULL
1770	NULL
A	NULL
Yy	NULL
R	NULL
I	NULL
b	NULL
¥	NULL
bos	NULL
L	NULL
k	NULL
L	NULL
K	NULL
®	NULL
D	NULL
$	NULL
L	NULL
G	NULL
A	NULL
B	NULL
S	NULL
R	NULL
BOI	NULL
E	NULL
D	NULL
590	NULL
GACCAAGAAGTATATGATGATGTTGCAGAGCAGGATGATATTAGCAGCCACAGTCACAGTGGAACTCCACCCATA	NULL
1845	NULL
D	NULL
Q	NULL
E	NULL
V	NULL
¥	NULL
b	NULL
D	NULL
y	NULL
A	NULL
E	NULL
0	NULL
b	NULL
p	NULL
i	NULL
s	NULL
$	NULL
E	NULL
s	NULL
0	NULL
cos	NULL
o	NULL
c	NULL
If	NULL
615	NULL
TPCCCTCCACCACCAGATCATGACATTTATGATGGGATTIGAAGAGGAAGATGCTEATGATGGTTTCCCTGCTCCT	NULL
1920	NULL
FOR	NULL
B	NULL
B	NULL
B	NULL
D	NULL
D	NULL
b	NULL
I	NULL
¥	NULL
b	NULL
G	NULL
I	NULL
E	NULL
B	NULL
B	NULL
D	NULL
A	NULL
D	NULL
D	NULL
G	NULL
F	NULL
P	NULL
A	NULL
P	NULL
640	NULL
CCTARMACAATTGGACATGGGAGATGAAGTTCACGATCATCTGGATACCTCTGATTTCCCTCITICATCAGCAGAG	NULL
1995	NULL
BoK	NULL
Q	NULL
L	NULL
D	NULL
M	NULL
@	NULL
D	NULL
E	NULL
V	NULL
Y	NULL
D	NULL
D	NULL
V	NULL
D	NULL
T	NULL
S	NULL
D	NULL
F	NULL
BR	NULL
V	NULL
S	NULL
S	NULL
A	NULL
®	NULL
665	NULL
ATGAGTCARGGAACTAATITT	NULL
AGCTAMGACAGCAMGARAAGCACCTTARGAAGCTAAAAAAGCAGGAAAAA	NULL
2070	NULL
Mos	NULL
Q	NULL
G	NULL
t	NULL
NOF	NULL
G	NULL
K	NULL
A	NULL
K	NULL
T	NULL
E	NULL
B	NULL
K	NULL
KOL	NULL
®	NULL
K	NULL
Q	NULL
E	NULL
®	NULL
-	NULL
630	NULL
GaRGAAAAAGACTTCAGCAAAAAATTTAAATATGATGGTGAAATTAGAGTCCTATATTCRACTAAAGITACAACT	NULL
2145	NULL
EOR	NULL
X	NULL
D	NULL
F	NULL
R	NULL
XK	NULL
K	NULL
F	NULL
K	NULL
¥	NULL
D	NULL
@	NULL
E	NULL
If	NULL
R	NULL
vom	NULL
¥	NULL
s	NULL
P	NULL
®	NULL
v	NULL
T	NULL
fo	NULL
718	NULL
TCCATAACTTCTAAAAAGTCGGGAACCAGAGATCTACAGCTAAAACCTCGTGARTCTCTACAACTTATACAAACC	NULL
2220	NULL
s	NULL
I	NULL
T	NULL
S	NULL
&	NULL
w	NULL
6	NULL
ROD	NULL
L	NULL
Q	NULL
Y	NULL
BOG	NULL
B	NULL
s	NULL
L	NULL
B	NULL
v	NULL
I	NULL
g	NULL
0m	NULL
740	NULL
ACAGATGACACAAAAGTTCTCTGCAGAAATGAAGAAGGGAAATATGGTTATGTCCTTCGGAGTTACCTAGCGGAC	NULL
2295	NULL
®	NULL
D	NULL
Dom	NULL
K	NULL
V	NULL
L	NULL
C	NULL
R	NULL
N	NULL
E	NULL
B	NULL
c	NULL
K	NULL
¥	NULL
c	NULL
¥	NULL
v	NULL
Ln	NULL
ROS	NULL
¥	NULL
L	NULL
A	NULL
B	NULL
765	NULL
AATGATGGAGAGATCTATGATGATATTGCTGATESCTECATCTATGACARTGACTAGCACTCAACTTTGGTCATT	NULL
2370	NULL
wo	NULL
D	NULL
G	NULL
k	NULL
a	NULL
¥	NULL
p	NULL
b	NULL
f	NULL
A	NULL
b	NULL
G	NULL
C	NULL
If	NULL
¥	NULL
D	NULL
N	NULL
D	NULL
.	NULL

H	NULL
8	NULL
T	NULL
L	NULL
v	NULL
I	NULL
790	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Amino	NULL
acid	NULL
and	NULL
eDNA	NULL
sequence	NULL
of	NULL
SLAP-130	NULL
.	NULL

The	NULL
130-kDa	NULL
protein	NULL
which	NULL
co-precipitates	NULL
with	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
was	NULL
subjected	NULL
to	NULL
tryptic	NULL
digestion	NULL
for	NULL
protein	NULL
sequencing	NULL
.	NULL

A	NULL
peptide	NULL
containing	NULL
the	NULL
sequence	NULL
PPNDVLTK	NULL
(	NULL
under/ined	NULL
)	NULL
was	NULL
found	NULL
to	NULL
be	NULL
encoded	NULL
by	NULL
an	NULL
EST	NULL
clone	NULL
which	NULL
was	NULL
used	NULL
to	NULL
isolate	NULL
coding	NULL
sequence	NULL
5	NULL
'	NULL
of	NULL
the	NULL
EST	NULL
from	NULL
a	NULL
human	NULL
thymus	NULL
cDNA	NULL
library	NULL
.	NULL

The	NULL
remaining	NULL
cDNA	NULL
was	NULL
amplified	NULL
by	NULL
3°	NULL
RACE	NULL
using	NULL
total	NULL
RNA	NULL
from	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
sequence	NULL
shown	NULL
represents	NULL
a	NULL
contiguous	NULL
cDNA	NULL
clone	NULL
amplified	NULL
from	NULL
Jurkat	NULL
RNA	NULL
by	NULL
PCR	NULL
.	NULL

cells	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
precipitated	NULL
by	NULL
the	NULL
wild	NULL
type	NULL
SLP-76	NULL
SH2	NULL
domain	NULL
migrates	NULL
identically	NULL
to	NULL
a	NULL
protein	NULL
detected	NULL
by	NULL
anti-FLAG	NULL
immunoblot	NULL
analysis	NULL
of	NULL
an	NULL
anti-FLAG	NULL
immunoprecipitate	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
or	NULL
whole	NULL
cell	NULL
lysates	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
from	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
pEF/SLAP-130	NULL
.	NULL

Additionally	NULL
,	NULL
the	NULL
FLAG-SLAP-130	NULL
protein	NULL
migrates	NULL
identically	NULL
to	NULL
an	NULL
endogenous	NULL
tyrosine-phosphorylated	NULL
protein	NULL
precipitated	NULL
by	NULL
the	NULL
SLP-76	NULL
SH2	NULL
fusion	NULL
protein	NULL
from	NULL
untransfected	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
pervanadate	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

SLAP-130	NULL
and	NULL
SLP-76	NULL
Associate	NULL
in	NULL
Cells-The	NULL
association	NULL
of	NULL
SLP-76	NULL
and	NULL
SLAP-130	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
was	NULL
investigated	NULL
using	NULL
anti-SLAP-130	NULL
sheep	NULL
antiserum	NULL
.	NULL

The	NULL
anti-SLAP-130	NULL
anti-serum	NULL
,	NULL
but	NULL
not	NULL
preimmune	NULL
serum	NULL
,	NULL
precipitates	NULL
and	NULL
immuno-blots	NULL
a	NULL
protein	NULL
of	NULL
130	NULL
kDa	NULL
in	NULL
Jurkat	NULL
T	NULL
cell	NULL
lysates	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
SLAP-130	NULL
and	NULL
SLP-76	NULL
associate	NULL
within	NULL
cells	NULL
,	NULL
lysates	NULL
were	NULL
prepared	NULL
from	NULL
resting	NULL
and	NULL
pervanadate	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
.	NULL

These	NULL
lysates	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-SLP-76	NULL
,	NULL
followed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
with	NULL
anti-SLAP-130	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
SLAP-130	NULL
is	NULL
present	NULL
in	NULL
SLP-76	NULL
immunoprecipitates	NULL
from	NULL
resting	NULL
Jurkat	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
tyrosine-phosphorylated	NULL
SLAP-130	NULL
seen	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
and	NULL
our	NULL
previous	NULL
finding	NULL
of	NULL
a	NULL
130-kDa	NULL
phosphoprotein	NULL
associated	NULL
with	NULL
SLP-76	NULL
in	NULL
resting	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
interaction	NULL
is	NULL
not	NULL
always	NULL
demonstrated	NULL
SLAP-130	NULL
,	NULL
a	NULL
Novel	NULL
Substrate	NULL
of	NULL
the	NULL
TCR-stimulated	NULL
PTK	NULL
a	NULL
€	NULL
3	NULL
E	NULL
-	NULL
E	NULL
FS	NULL
5	NULL
kore	NULL
B	NULL
P	NULL
§	NULL
®	NULL
o	NULL
wos	NULL
m	NULL
g	NULL
fk	NULL
£4	NULL
f	NULL
5	NULL
®	NULL
i	NULL
Tissue	NULL
Eﬁééé	NULL
’	NULL
ggéa	NULL
‘	NULL
j	NULL
‘	NULL
]	NULL
33.1545	NULL
?	NULL

-	NULL
95	NULL
*~	NULL
(	NULL
7.6	NULL
SLAP-130-	NULL
»	NULL
__	NULL
#	NULL
us	NULL
=	NULL
#	NULL
4	NULL
-	NULL
24	NULL
-	NULL
14	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Tissue	NULL
distribution	NULL
of	NULL
SLAP-130	NULL
mRNA	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
the	NULL
indicated	NULL
tissues	NULL
demonstrates	NULL
expression	NULL
of	NULL
SLAP-130	NULL
in	NULL
the	NULL
lymphoid	NULL
compartment	NULL
.	NULL

SLAP-180	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
,	NULL
thymus	NULL
,	NULL
and	NULL
spleen	NULL
cells	NULL
.	NULL

x	NULL
&	NULL
4	NULL
a	NULL
A	NULL
B	NULL
&	NULL
f	NULL
;	NULL
g	NULL
in	NULL
5	NULL
i	NULL
|	NULL
ul	NULL
8	NULL
@	NULL
I	NULL
kDa	NULL
2	NULL
r-1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
7	NULL
20	NULL
-	NULL
«	NULL
i	NULL
.	NULL

+-	NULL
SLAP	NULL
:	NULL
A130	NULL
19	NULL
203	NULL
kDa	NULL
--	NULL
80	NULL
=	NULL
--	NULL
118	NULL
kDa	NULL
-	NULL
E	NULL
+-	NULL
SLAP-130	NULL
50	NULL
=	NULL
--	NULL
4	NULL
8	NULL
86	NULL
kD	NULL
.	NULL

1	NULL
9	NULL
86	NULL
kDa	NULL
P	NULL
%	NULL
,	NULL
PV	NULL
-o	NULL
4	NULL
>	NULL
40	NULL
>	NULL
o	NULL
>	NULL
+	NULL
F	NULL
”	NULL
LL	NULL
:	NULL
I	NULL
J	NULL
I	NULL
J	NULL
a	NULL
cFlag	NULL
wPY	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

SLAP-130	NULL
is	NULL
a	NULL
130-kDa	NULL
protein	NULL
precipitated	NULL
by	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
.	NULL

A	NULL
,	NULL
lysates	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
pEF/SLAP-130	NULL
contain	NULL
a	NULL
180-kDa	NULL
protein	NULL
reactive	NULL
with	NULL
anti-FLAG	NULL
mAb	NULL
.	NULL

B	NULL
,	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
precipitates	NULL
the	NULL
epitope-tagged	NULL
SLAP-130	NULL
from	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
transfected	NULL
with	NULL
pEF/SLAP-180	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
Zanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
for	NULL
1	NULL
min	NULL
with	NULL
pervanadate	NULL
(	NULL
PV	NULL
)	NULL
.	NULL

Lysates	NULL
prepared	NULL
from	NULL
3	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
GST	NULL
fusion	NULL
protein	NULL
encoding	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
(	NULL
GST	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
an	NULL
analogous	NULL
fusion	NULL
protein	NULL
containing	NULL
a	NULL
loss	NULL
of	NULL
function	NULL
SLP-76	NULL
SH2	NULL
domain	NULL
(	NULL
GST	NULL
/R448K	NULL
;	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

GST	NULL
fusion	NULL
protein	NULL
precipitates	NULL
as	NULL
well	NULL
as	NULL
anti-FLAG	NULL
immunoprecipitate	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
and	NULL
whole	NULL
cell	NULL
lysate	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
with	NULL
anti-FLAG	NULL
mAb	NULL
.	NULL

Additionally	NULL
,	NULL
anti-phosphotyrosine	NULL
(	NULL
«	NULL
-PY	NULL
)	NULL
Western	NULL
blot	NULL
of	NULL
a	NULL
GST/SH2	NULL
precipitate	NULL
from	NULL
untransfected	NULL
pervanadate-stimulated	NULL
Jurkat	NULL
cells	NULL
demonstrates	NULL
that	NULL
the	NULL
130-kDa	NULL
protein	NULL
associated	NULL
with	NULL
the	NULL
SH2	NULL
domain	NULL
of	NULL
SLP-76	NULL
migrates	NULL
the	NULL
same	NULL
as	NULL
SLAP-180	NULL
(	NULL
Zane	NULL
7	NULL
)	NULL
.	NULL

in	NULL
the	NULL
resting	NULL
state	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
SLAP-130	NULL
associating	NULL
with	NULL
SLP-76	NULL
increases	NULL
following	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
with	NULL
pervanadate	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
whether	NULL
SLAP-130	NULL
is	NULL
a	NULL
substrate	NULL
of	NULL
the	NULL
TCR-induced	NULL
PTKs	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
or	NULL
pervanadate	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
whole	NULL
cell	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-SLAP-130	NULL
antiserum	NULL
followed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
with	NULL
anti-phosphotyrosine	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
fop	NULL
panel	NULL
)	NULL
.	NULL

As	NULL
noted	NULL
above	NULL
,	NULL
there	NULL
is	NULL
a	NULL
basal	NULL
level	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SLAP-130	NULL
in	NULL
resting	NULL
Jurkat	NULL
.	NULL

TCR-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SLAP-130	NULL
occurs	NULL
maximally	NULL
at	NULL
1	NULL
min	NULL
and	NULL
diminishes	NULL
to	NULL
basal	NULL
levels	NULL
within	NULL
15	NULL
min	NULL
of	NULL
TCR	NULL
stimula-tion	NULL
.	NULL

To	NULL
demonstrate	NULL
equal	NULL
loading	NULL
of	NULL
SLAP-130	NULL
in	NULL
each	NULL
lane	NULL
,	NULL
the	NULL
anti-phosphotyrosine	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-SLAP-130	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
SLAP-130	NULL
Interferes	NULL
with	NULL
TCR-mediated	NULL
Activation	NULL
of	NULL
NFAT-We	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
that	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
augments	NULL
TCR	NULL
signals	NULL
leading	NULL
to	NULL
IL-2	NULL
promoter	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Since	NULL
a	NULL
functional	NULL
SH2	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
SLP-76	NULL
activity	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
7	NULL
)	NULL
,	NULL
we	NULL
speculated	NULL
that	NULL
proteins	NULL
associated	NULL
with	NULL
the	NULL
SLP-76	NULL
SH2	NULL
domain	NULL
would	NULL
also	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
SLAP-130	NULL
,	NULL
a	NULL
Novel	NULL
Substrate	NULL
of	NULL
the	NULL
TCR-stimulated	NULL
PTK	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
kDa	NULL
kDa	NULL
120	NULL
-	NULL
summ	NULL
cmm	NULL
i	NULL
130	NULL
.	NULL

-	NULL
Mm	NULL
:	NULL
lii	NULL
_	NULL
120	NULL
80	NULL
-	NULL
.	NULL

d	NULL
-	NULL
80	NULL
-	NULL
.	NULL

!	NULL

50	NULL
-	NULL
he	NULL
®	NULL
$	NULL
0	NULL
g	NULL
f	NULL
-o	NULL
40	NULL
PV	NULL
3	NULL
o	NULL
F	NULL
Dog	NULL
5	NULL
$	NULL
=a	NULL
&	NULL
&	NULL
B	NULL
time	NULL
(	NULL
min	NULL
)	NULL
-	NULL
0	NULL
10	NULL
500	NULL
400	NULL
450	NULL
so	NULL
_	NULL
6000	NULL
PV	NULL
kDa	NULL
wPY	NULL
-+	NULL
es	NULL
cso	NULL
*	NULL
-120	NULL
-	NULL
80	NULL
-SLAP-130	NULL
--	NULL
essen	NULL
wee	NULL
o-	NULL
come	NULL
cme	NULL
cmm	NULL
ose	NULL
-o	NULL
=-=120	NULL
-	NULL
80	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

SLAP-130	NULL
associates	NULL
with	NULL
SLP-76	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
a	NULL
substrate	NULL
of	NULL
the	NULL
TCR-induced	NULL
PTKs	NULL
.	NULL

A	NULL
,	NULL
Anti-SLAP-130	NULL
antiserum	NULL
is	NULL
reactive	NULL
with	NULL
a	NULL
180-kDa	NULL
protein	NULL
that	NULL
co-precipitates	NULL
with	NULL
SLP-76	NULL
.	NULL

3	NULL
x	NULL
10	NULL
``	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
either	NULL
preimmune	NULL
serum	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
anti-SLAP-130	NULL
antiserum	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

These	NULL
immune	NULL
complexes	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
whole	NULL
cell	NULL
lysates	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
anti-SLAP-180	NULL
antiserum	NULL
.	NULL

Whole	NULL
cell	NULL
lysates	NULL
prepared	NULL
from	NULL
5	NULL
X	NULL
10°	NULL
unstimulated	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
pervanadate-stimulated	NULL
(	NULL
ane	NULL
5	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-SLP-76	NULL
antiserum	NULL
and	NULL
then	NULL
immunoblotted	NULL
with	NULL
anti-SLP-76	NULL
(	NULL
bottom	NULL
panel	NULL
)	NULL
and	NULL
anti-SLAP-130	NULL
(	NULL
top	NULL
panel	NULL
)	NULL
antisera	NULL
.	NULL

B	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SLAP-180	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

2	NULL
X	NULL
10	NULL
``	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
(	NULL
C305	NULL
acites	NULL
1:1000	NULL
)	NULL
for	NULL
indicated	NULL
times	NULL
or	NULL
pervanadate	NULL
for	NULL
1	NULL
min	NULL
.	NULL

Whole	NULL
cell	NULL
lysates	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
anti-SLAP-180	NULL
antiserum	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
anti-phosphotyrosine	NULL
mAb	NULL
(	NULL
@	NULL
-PY	NULL
,	NULL
top	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
«	NULL
-PY	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-SLAP-130	NULL
antiserum	NULL
(	NULL
Zower	NULL
panel	NULL
)	NULL
to	NULL
demonstrate	NULL
the	NULL
amount	NULL
of	NULL
SLAP-130	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

regulate	NULL
signals	NULL
through	NULL
the	NULL
TCR	NULL
in	NULL
a	NULL
positive	NULL
manner	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
SLAP-130	NULL
on	NULL
signals	NULL
generated	NULL
by	NULL
TCR	NULL
ligation	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
pEF/	NULL
SLAP-130	NULL
or	NULL
a	NULL
control	NULL
vector	NULL
and	NULL
a	NULL
luciferase	NULL
reporter	NULL
construct	NULL
driven	NULL
by	NULL
the	NULL
NFAT	NULL
response	NULL
element	NULL
.	NULL

Fig	NULL
.	NULL

5A	NULL
demonstrates	NULL
that	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
effect	NULL
of	NULL
SLP-76	NULL
on	NULL
T	NULL
cell	NULL
signaling	NULL
,	NULL
overexpression	NULL
of	NULL
SLAP-130	NULL
results	NULL
in	NULL
diminished	NULL
NFAT	NULL
activity	NULL
following	NULL
TCR	NULL
ligation	NULL
.	NULL

Furthermore	NULL
,	NULL
co-trans-fection	NULL
of	NULL
SLAP-130	NULL
and	NULL
SLP-76	NULL
reveals	NULL
that	NULL
overexpression	NULL
of	NULL
SLAP-130	NULL
inhibits	NULL
the	NULL
augmentation	NULL
of	NULL
TCR-stimulated	NULL
IL-2	NULL
promoter	NULL
activity	NULL
by	NULL
SLP-76	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
FLAG-tagged	NULL
cDNAs	NULL
was	NULL
confirmed	NULL
by	NULL
immunoblotting	NULL
whole	NULL
cell	NULL
lysates	NULL
with	NULL
anti-FLAG	NULL
mAb	NULL
.	NULL

We	NULL
were	NULL
surprised	NULL
to	NULL
discover	NULL
that	NULL
overexpression	NULL
of	NULL
SLAP-130	NULL
appears	NULL
to	NULL
interfere	NULL
with	NULL
TCR-induced	NULL
NFAT	NULL
activation	NULL
in	NULL
Jurkat	NULL
cells	NULL
and	NULL
,	NULL
additionally	NULL
,	NULL
inhibits	NULL
the	NULL
ability	NULL
of	NULL
transfected	NULL
SLP-76	NULL
to	NULL
augment	NULL
TCR	NULL
responses	NULL
.	NULL

Unfortunately	NULL
,	NULL
the	NULL
primary	NULL
sequence	NULL
of	NULL
SLAP-130	NULL
does	NULL
not	NULL
provide	NULL
insight	NULL
into	NULL
how	NULL
it	NULL
may	NULL
function	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
TCR-induced	NULL
NFAT	NULL
activa-tion	NULL
.	NULL

Structure-function	NULL
experiments	NULL
are	NULL
ongoing	NULL
to	NULL
determine	NULL
the	NULL
regions	NULL
of	NULL
SLAP-130	NULL
required	NULL
for	NULL
its	NULL
inhibitory	NULL
effects	NULL
.	NULL

Northern	NULL
blot	NULL
analyses	NULL
indicate	NULL
that	NULL
SLP-76	NULL
and	NULL
SLAP-130	NULL
are	NULL
expressed	NULL
coordinately	NULL
in	NULL
hematopoietic	NULL
tissues	NULL
.	NULL

Defining	NULL
their	NULL
role	NULL
in	NULL
other	NULL
hematopoietic	NULL
cells	NULL
may	NULL
provide	NULL
insight	NULL
into	NULL
how	NULL
these	NULL
proteins	NULL
regulate	NULL
T	NULL
cell	NULL
signals	NULL
.	NULL

We	NULL
have	NULL
found	NULL
an	NULL
association	NULL
between	NULL
the	NULL
SLP-76	NULL
SH2	NULL
domain	NULL
and	NULL
a	NULL
130-kDa	NULL
protein	NULL
in	NULL
rat	NULL
basophillic	NULL
leukemia	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Since	NULL
engagement	NULL
11677	NULL
207	NULL
MB	NULL
unstimulated	NULL
102	NULL
s	NULL
4	NULL
jg	NULL
|	NULL
C	NULL
TCR	NULL
stimulated	NULL
«	NULL
-	NULL
SI	NULL
AP-130	NULL
aome	NULL
._	NULL
.	NULL

giliiith	NULL
«	NULL
-	NULL
G|	NULL
p.76	NULL
sp	NULL
16-9	NULL
14	NULL
o-Flag	NULL
o	NULL
a	NULL
#	NULL
12	NULL
=	NULL
am	NULL
ao	NULL
10	NULL
&	NULL
©	NULL
Q	NULL
8-	NULL
F	NULL
--	NULL
-'to	NULL
F	NULL
--	NULL
-3	NULL
6	NULL
wad	NULL
4	NULL
2-	NULL
M	NULL
0	NULL
,	NULL
_	NULL
commmmmeal	NULL
.	NULL

r-A2	NULL
SLP	NULL
SLAP	NULL
SLP+SLAP	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Overexpression	NULL
of	NULL
SLAP-130	NULL
diminishes	NULL
transcrip-tional	NULL
activation	NULL
through	NULL
the	NULL
NFAT	NULL
response	NULL
element	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
NFAT-luc	NULL
,	NULL
cytomegalovirus-B-galactosidase	NULL
,	NULL
and	NULL
either	NULL
vector	NULL
control	NULL
,	NULL
pEF/SLP-76	NULL
,	NULL
pEF/SLAP-180	NULL
,	NULL
or	NULL
both	NULL
pEF/	NULL
SLAP-180	NULL
and	NULL
pEF/SLP-76	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
DNA	NULL
in	NULL
each	NULL
sample	NULL
was	NULL
equalized	NULL
with	NULL
vector	NULL
control	NULL
.	NULL

24	NULL
h	NULL
following	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
in	NULL
triplicate	NULL
with	NULL
anti-TCR	NULL
mAb	NULL
for	NULL
10	NULL
h	NULL
and	NULL
then	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

Luciferase	NULL
light	NULL
units	NULL
were	NULL
normalized	NULL
to	NULL
B-galactosidase	NULL
activity	NULL
in	NULL
each	NULL
transfectant	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
epitope-tagged	NULL
constructs	NULL
was	NULL
determined	NULL
by	NULL
preparing	NULL
whole	NULL
cell	NULL
lysates	NULL
from	NULL
10°	NULL
transfected	NULL
cells	NULL
and	NULL
immunoblotting	NULL
with	NULL
anti-FLAG	NULL
mAb	NULL
.	NULL

of	NULL
the	NULL
high	NULL
affinity	NULL
receptor	NULL
for	NULL
IgE	NULL
on	NULL
rat	NULL
basophillic	NULL
leukemia	NULL
cells	NULL
leads	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
SLP-76	NULL
(	NULL
15	NULL
)	NULL
,	NULL
experiments	NULL
are	NULL
ongoing	NULL
to	NULL
determine	NULL
if	NULL
overexpression	NULL
of	NULL
SLP-76	NULL
augments	NULL
signaling	NULL
events	NULL
downstream	NULL
of	NULL
receptor	NULL
binding	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
if	NULL
overexpression	NULL
of	NULL
SLAP-130	NULL
impacts	NULL
negatively	NULL
on	NULL
signal	NULL
transduction	NULL
via	NULL
the	NULL
IgE	NULL
receptor	NULL
.	NULL

It	NULL
will	NULL
be	NULL
important	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
down-regulation	NULL
of	NULL
TCR-induced	NULL
NFAT	NULL
activation	NULL
by	NULL
overexpression	NULL
of	NULL
SLAP-130	NULL
requires	NULL
an	NULL
interaction	NULL
between	NULL
SLP-76	NULL
and	NULL
SLAP-130	NULL
.	NULL

Experiments	NULL
are	NULL
in	NULL
progress	NULL
to	NULL
determine	NULL
the	NULL
site	NULL
on	NULL
SLAP-130	NULL
responsible	NULL
for	NULL
its	NULL
interaction	NULL
with	NULL
SLP-76	NULL
.	NULL

Manipulation	NULL
of	NULL
the	NULL
SLAP-130	NULL
cDNA	NULL
prior	NULL
to	NULL
transfection	NULL
into	NULL
Jurkat	NULL
cells	NULL
expressing	NULL
wild	NULL
type	NULL
or	NULL
overexpressed	NULL
levels	NULL
of	NULL
SLP-76	NULL
will	NULL
facilitate	NULL
our	NULL
understanding	NULL
of	NULL
how	NULL
these	NULL
two	NULL
molecules	NULL
may	NULL
interact	NULL
to	NULL
regulate	NULL
signals	NULL
downstream	NULL
of	NULL
TCR	NULL
engagement	NULL
.	NULL

REFERENCES	NULL
.	NULL

Howe	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20	NULL
,	NULL
59-64	NULL
2	NULL
.	NULL

Jackman	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Sun	NULL
,	NULL
Q.	NULL
,	NULL
Tanemoto	NULL
,	NULL
M.	NULL
,	NULL
Turck	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
Peltz	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
Findell	NULL
,	NULL
P.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
7029-7082	NULL
3	NULL
.	NULL

Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Ross	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Jackman	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Sun	NULL
,	NULL
Q.	NULL
,	NULL
Olson	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Findell	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
21608-21613	NULL
4	NULL
.	NULL

Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Ross	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Wu	NULL
,	NULL
J.	NULL
,	NULL
Hendricks-Taylor	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
1937-1948	NULL
5	NULL
.	NULL

Wu	NULL
,	NULL
J.	NULL
,	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
Weiss	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
593-602	NULL
6	NULL
.	NULL

Fang	NULL
,	NULL
N.	NULL
,	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Ross	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
3769-3773	NULL
7	NULL
.	NULL

Wardenburg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Fu	NULL
,	NULL
C.	NULL
,	NULL
Jackman	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Flotow	NULL
,	NULL
H.	NULL
,	NULL
Wilkinson	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Williams	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Johnson	NULL
,	NULL
R.	NULL
,	NULL
Kong	NULL
,	NULL
G.	NULL
,	NULL
Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Findell	NULL
,	NULL
P.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
19641-19644	NULL
8	NULL
.	NULL

Onodera	NULL
,	NULL
H.	NULL
,	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
Rothstein	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
22225-22280	NULL
9	NULL
.	NULL

Tuosto	NULL
,	NULL
L.	NULL
,	NULL
Michel	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Acuto	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184	NULL
,	NULL
1161-1167	NULL
10	NULL
.	NULL

Musci	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Beaves	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Ross	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Yi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
1565-1571	NULL
11	NULL
.	NULL

Secrist	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Burns	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Karnitz	NULL
,	NULL
L.	NULL
,	NULL
Koretzky	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
Abraham	NULL
,	NULL
R.	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
5886-5893	NULL
12.	NULL
van	NULL
den	NULL
Hoff	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Moorman	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
and	NULL
Lamers	NULL
,	NULL
W.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
2902	NULL
13	NULL
.	NULL

Robbins	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Dilworth	NULL
,	NULL
R.	NULL
,	NULL
Laskey	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Dingwall	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
615-623	NULL
14	NULL
.	NULL

Songyang	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Cantley	NULL
,	NULL
L.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20	NULL
,	NULL
470-475	NULL
15	NULL
.	NULL

Hendricks-Taylor	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
Motto	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Zhang	NULL
,	NULL
J.	NULL
,	NULL
Siraganian	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
and	NULL
Koretzky	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
1363-1367	NULL
a	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Molecular	NULL
Cloning	NULL
of	NULL
SLAP-130	NULL
,	NULL
an	NULL
SLP-76-associated	NULL
Substrate	NULL
of	NULL
the	NULL
T	NULL
Cell	NULL
Antigen	NULL
Receptor-stimulated	NULL
Protein	NULL
Tyrosine	NULL
Kinases	NULL
Michael	NULL
A.	NULL
Musci	NULL
,	NULL
L.	NULL
Ranee	NULL
Hendricks-Taylor	NULL
,	NULL
David	NULL
G.	NULL
Motto	NULL
,	NULL
Michael	NULL
Paskind	NULL
,	NULL
Joanne	NULL
Kamens	NULL
,	NULL
Christoph	NULL
W.	NULL
Turck	NULL
and	NULL
Gary	NULL
A.	NULL
Koretzky	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:11674-11677.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.18.11674	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/18/11674	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
15	NULL
references	NULL
,	NULL
10	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
1674.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

